[Long-time results of intracavitary isotope therapy of malignant effusions].
D001202:Ascitic Fluid; D002840:Chromates; D005260:Female; D005500:Follow-Up Studies; D006048:Gold Colloid, Radioactive / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D010166:Palliative Care; D010529:Peritoneal Cavity; D010532:Peritoneal Diseases / Q000209:etiology / Q000532:radiotherapy*; D010761:Phosphorus Radioisotopes; D010996:Pleural Effusion / Q000209:etiology / Q000532:radiotherapy*; D011677:Punctures; D011868:Radioisotopes / Q000627:therapeutic use*; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D012824:Silicic Acid; D013997:Time Factors; D015020:Yttrium Isotopes / Q000627:therapeutic use*
D002840:Chromates; D006048:Gold Colloid, Radioactive; D010761:Phosphorus Radioisotopes; D011868:Radioisotopes; D015020:Yttrium Isotopes; D012824:Silicic Acid
Langzeitergebnisse der intrakavitären Isotopentherapie maligner Ergüsse